300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Oman
Romania
Puerto Rico
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Ghana
Denmark
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Indonesia
Germany
United States
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Argentina
Cyprus
Barbados
Belgium
Austria
Ethiopia
Jordan
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Liechtenstein
Lithuania
Honduras
Iceland
Lebanon
Cambodia
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Qisheng Capital

VC Fund

Baoshan, China

Qisheng Capital is an investment firm that offer investment management and consulting service.

Total investments:
6
Last investment:
Lead investor:
0%

Last updated:

Industries Qisheng Capital invests in

BiotechnologyPharmaceuticalBiopharmaManufacturingElectronics

Stages Qisheng Capital invests in

Series BAngelSeries CVenture - Series Unknown

Countries Qisheng Capital invests in

China

Investment Focus

Industry

  • Biotechnology 3 (50%)
  • Pharmaceutical 3 (50%)
  • Biopharma 2 (33%)
  • Manufacturing 2 (33%)
  • Electronics 1 (17%)
See all 9 industries →

Stage

  • Series B 3 (50%)
  • Angel 1 (17%)
  • Series C 1 (17%)
  • Venture - Series Unknown 1 (17%)

Investments

CompanyDescriptionRoundLinks
Yanming Biology Yanming Biology
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. Series B / Jul 03, 2026
XellSmart XellSmart
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. $72.6M / Series C / Apr 01, 2026
XellSmart XellSmart
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. $14M / Series B / Oct 21, 2024
Fujian Technology
Futan Technology specializes in the research and development of isostatic graphite materials. $13.7M / Series B / Aug 30, 2023
Gloria spectrum Gloria spectrum
Gloria spectrum offers mass spectrometry applications as its core technology as well as multi-omics data-driven product innovation strategy. Venture - Series Unknown / May 05, 2022
Tongming Tongming
Tongming specializes in auto parts design and manufacturing services. $425K / Angel / Apr 28, 2017

Co-Investors

Frees Fund Frees Fund 2 deals together
Shanghai Minjin Investment 2 deals together
Suzhou Angel Fund of Funds Suzhou Angel Fund of Funds 2 deals together
Beijing Medical and Health Industry Investment Fund Beijing Medical and Health Industry Investment Fund 1 deal together
Chang Development Chang Development 1 deal together
China Win Fund China Win Fund 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Oman
Romania
Puerto Rico
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Ghana
Denmark
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Indonesia
Germany
United States
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Argentina
Cyprus
Barbados
Belgium
Austria
Ethiopia
Jordan
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Liechtenstein
Lithuania
Honduras
Iceland
Lebanon
Cambodia
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Qisheng Capital invest in?

Qisheng Capital invests primarily in Biotechnology, Pharmaceutical and Biopharma startups, most often at Series B and Angel stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Qisheng Capital last invest?

The most recent investment recorded for Qisheng Capital closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Qisheng Capital Find emails